Empagliflozin in combination therapy for treating type 2 diabetes

Supporting evidence

• Review decision

• Review decision – March 2018

• Review decision paper (PDF 397 KB)

  Published:

  30 March 2018

• Matrix of stakeholders (PDF 261 KB)

  Published:

  30 March 2018